Stock Evaluator: Alpha Tau Medical Ltd. (DRTS)

Alpha Tau Medical Ltd. DRTS

$11.61 0.30 2.68%
November 20, 2026 1:25:04 PM EST November 10, 2021 Volume: 340,495
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.

Commentary & Analysis


Financial Summary

Share Statistics DRTS Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $1,044.3 $356.4 47%
Shares Out (Mil) 91.0 41.2 60%
Institutional Ownership 45.9% 83.1% 19%
Float (Mil) 64.1 36.7 52%
Beta 1.18 0.89 69%
Avg Daily Volume (000s) 846 318 67%
Price Change
(52-week)
207.3% 55.9% 99%
Growth DRTS Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 11.8% na
Net Income (5yr) (36.8%) (5.8%) 11%
EPS (5yr) (19.1%) 10.6% 14
Dividends (5yr) na 0.0% na
Cash Flow (5yr) (15.5%) (15.6%) 48%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 4 5 5
Current EPS ($0.152) ($0.963) ($0.539)
Month Ago EPS ($0.147) ($0.955) ($0.535)
# Rev Up 0 0 0
# Rev Down 1 2 3
Three Months Ago EPS ($0.142) ($0.878) ($0.527)
Year/Year Chg (69.8%) 82.0% (3.6%)
Financials DRTS Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) na $123 na
Net Income (TTM) (Mil) ($93) ($9) 11%
EPS (TTM) ($1.052) ($0.300) 20%
Operating Cash Flow (TTM) (Mil) ($13) ($1) 18%
Net Cash Flow (TTM) (Mil) na $2 na
Long-Term Debt (Q1) (Mil) $14 $21 30%
Enterprise Value (Q1) (Mil) $1,231 $381 44%
Valuation DRTS Industry
Median
Percentile
(All Stocks)
P/B 23.56 2.46 97%
P/E na 25.5 na
Dividend Yield na 0.0% na
PEG (5yr hist) na 1.3 na
Ratios DRTS Industry
Median
Percentile
(All Stocks)
Gross Margin na 59.1% na
Net Margin na (4.6%) na
ROA (80.4%) (9.9%) 7%
ROE (156.8%) (8.5%) 5%
Liabilities to Assets 67.2% 45.6% 63%
F-Score 1 4 1%

Alpha Tau Medical Ltd. did not pass any screens on 11/19/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors